Actinium Pharmaceuticals (AMEX: ATNM)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Actinium Pharmaceuticals (AMEX: ATNM) through any online brokerage.
There are no as such competitors for Actinium Pharmaceuticals.
The latest price target for Actinium Pharmaceuticals (AMEX: ATNM) was reported by HC Wainwright & Co. on Tuesday, August 3, 2021. The analyst firm set a price target for 45.00 expecting ATNM to rise to within 12 months (a possible 673.86% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Actinium Pharmaceuticals (AMEX: ATNM) is $5.815 last updated August 17, 2022, 7:59 PM UTC.
There are no upcoming dividends for Actinium Pharmaceuticals.
Actinium Pharmaceuticals’s Q3 earnings are confirmed for Friday, November 11, 2022.
There is no upcoming split for Actinium Pharmaceuticals.
Actinium Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the AMEX.